U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Intra-epidermal blistering

MedGen UID:
1779880
Concept ID:
C5539821
Finding
HPO: HP:0033802

Definition

A type of blistering in which the lesions are located within the epidermis with loss of cell-cell adhesion of keratinocytes. In simplex EB, cleavage occurs in the basal layer, which is the innermost layer of the epidermis and consists of a single layer of basal germinative cells (mostly epidermal Keratinocytes) that proliferate and thereby produce new cells for other epidermal layers. As the cells move towards the upper layers of the epidermis they mature and eventually form cornified cells. The suprabasal cell layer lies directly above the basal layer and is composed of five to ten layers of cells. [from HPO]

Conditions with this feature

Epidermolysis bullosa simplex with mottled pigmentation
MedGen UID:
140934
Concept ID:
C0432316
Congenital Abnormality
Epidermolysis bullosa simplex (EBS) is characterized by fragility of the skin (and mucosal epithelia in some instances) that results in non-scarring blisters and erosions caused by minor mechanical trauma. EBS is distinguished from other types of epidermolysis bullosa (EB) or non-EB skin fragility syndromes by the location of the blistering in relation to the dermal-epidermal junction. In EBS, blistering occurs within basal keratinocytes. The severity of blistering ranges from limited to hands and feet to widespread involvement. Additional features can include hyperkeratosis of the palms and soles (keratoderma), nail dystrophy, milia, and hyper- and/or hypopigmentation. Rare EBS subtypes have been associated with additional clinical features including pyloric atresia, muscular dystrophy, cardiomyopathy, and/or nephropathy.
Epidermolysis bullosa simplex with migratory circinate erythema
MedGen UID:
324475
Concept ID:
C1836284
Disease or Syndrome
Epidermolysis bullosa simplex (EBS) is characterized by fragility of the skin (and mucosal epithelia in some instances) that results in non-scarring blisters and erosions caused by minor mechanical trauma. EBS is distinguished from other types of epidermolysis bullosa (EB) or non-EB skin fragility syndromes by the location of the blistering in relation to the dermal-epidermal junction. In EBS, blistering occurs within basal keratinocytes. The severity of blistering ranges from limited to hands and feet to widespread involvement. Additional features can include hyperkeratosis of the palms and soles (keratoderma), nail dystrophy, milia, and hyper- and/or hypopigmentation. Rare EBS subtypes have been associated with additional clinical features including pyloric atresia, muscular dystrophy, cardiomyopathy, and/or nephropathy.
Epidermolysis bullosa simplex 5C, with pyloric atresia
MedGen UID:
436922
Concept ID:
C2677349
Disease or Syndrome
Epidermolysis bullosa simplex 5C with pyloric atresia (EBS5C) is an autosomal recessive genodermatosis characterized by severe skin blistering at birth and congenital pyloric atresia. Death usually occurs in infancy. In reports of 2 consensus meetings for EB, Fine et al. (2000, 2008) considered EBSPA to be a 'basal' form of simplex EB because the electron microscopy shows that skin cleavage occurs in the lower basal level of the keratinocyte, just above the hemidesmosome. There is often decreased integration of keratin filaments with hemidesmosomes. See also forms of junctional EB with pyloric atresia, JEB5B (226730) and JEB6 (619817), caused by mutation in the ITGB4 (147557) and ITGA6 (147556) genes, respectively. For a discussion of genetic heterogeneity of the subtypes of EBS, see EBS1A (131760).
Epidermolysis bullosa simplex 5B, with muscular dystrophy
MedGen UID:
418981
Concept ID:
C2931072
Disease or Syndrome
Epidermolysis bullosa simplex (EBS) is characterized by fragility of the skin (and mucosal epithelia in some instances) that results in non-scarring blisters and erosions caused by minor mechanical trauma. EBS is distinguished from other types of epidermolysis bullosa (EB) or non-EB skin fragility syndromes by the location of the blistering in relation to the dermal-epidermal junction. In EBS, blistering occurs within basal keratinocytes. The severity of blistering ranges from limited to hands and feet to widespread involvement. Additional features can include hyperkeratosis of the palms and soles (keratoderma), nail dystrophy, milia, and hyper- and/or hypopigmentation. Rare EBS subtypes have been associated with additional clinical features including pyloric atresia, muscular dystrophy, cardiomyopathy, and/or nephropathy.
Epidermolysis bullosa simplex, Dowling-Meara type, with severe palmoplantar keratoderma
MedGen UID:
864672
Concept ID:
C4016235
Disease or Syndrome

Recent clinical studies

Etiology

Olbrich M, Künstner A, Witte M, Busch H, Fähnrich A
Front Immunol 2019;10:2327. Epub 2019 Oct 15 doi: 10.3389/fimmu.2019.02327. PMID: 31749790Free PMC Article
Didona D, Maglie R, Eming R, Hertl M
Front Immunol 2019;10:1418. Epub 2019 Jun 25 doi: 10.3389/fimmu.2019.01418. PMID: 31293582Free PMC Article
Chamcheu JC, Siddiqui IA, Syed DN, Adhami VM, Liovic M, Mukhtar H
Arch Biochem Biophys 2011 Apr 15;508(2):123-37. Epub 2010 Dec 19 doi: 10.1016/j.abb.2010.12.019. PMID: 21176769Free PMC Article

Diagnosis

Chamcheu JC, Siddiqui IA, Syed DN, Adhami VM, Liovic M, Mukhtar H
Arch Biochem Biophys 2011 Apr 15;508(2):123-37. Epub 2010 Dec 19 doi: 10.1016/j.abb.2010.12.019. PMID: 21176769Free PMC Article

Therapy

Didona D, Maglie R, Eming R, Hertl M
Front Immunol 2019;10:1418. Epub 2019 Jun 25 doi: 10.3389/fimmu.2019.01418. PMID: 31293582Free PMC Article

Prognosis

Didona D, Maglie R, Eming R, Hertl M
Front Immunol 2019;10:1418. Epub 2019 Jun 25 doi: 10.3389/fimmu.2019.01418. PMID: 31293582Free PMC Article
Chamcheu JC, Siddiqui IA, Syed DN, Adhami VM, Liovic M, Mukhtar H
Arch Biochem Biophys 2011 Apr 15;508(2):123-37. Epub 2010 Dec 19 doi: 10.1016/j.abb.2010.12.019. PMID: 21176769Free PMC Article

Clinical prediction guides

Olbrich M, Künstner A, Witte M, Busch H, Fähnrich A
Front Immunol 2019;10:2327. Epub 2019 Oct 15 doi: 10.3389/fimmu.2019.02327. PMID: 31749790Free PMC Article
Didona D, Maglie R, Eming R, Hertl M
Front Immunol 2019;10:1418. Epub 2019 Jun 25 doi: 10.3389/fimmu.2019.01418. PMID: 31293582Free PMC Article
Chen J, O'Shea C, Fitzpatrick JE, Koster MI, Koch PJ
Mol Carcinog 2012 Jul;51(7):535-45. Epub 2011 Jun 16 doi: 10.1002/mc.20818. PMID: 21681825Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...